首页 > 最新文献

Journal of Intensive Care最新文献

英文 中文
Case volume and specialization in critically ill emergency patients: a nationwide cohort study in Japanese ICUs. 急诊重症患者的病例量和专业化:日本重症监护病房的全国性队列研究。
IF 7.1 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-05-17 DOI: 10.1186/s40560-024-00733-3
Jun Fujinaga, Takanao Otake, Takehide Umeda, Toshio Fukuoka

Background: Previous studies have explored the association between the number of cases and patient outcomes for critical illnesses such as sepsis and trauma, as well as various surgeries, with the expectation that a higher number of cases would have a more favorable effect on patient outcomes. The aim of this study was to elucidate the association among intensive care unit (ICU) case volume, specialization, and patient outcomes in critically ill emergency patients and to determine how ICU case volumes and specializations impact the outcomes of these patients in Japanese ICUs.

Methods: Utilizing data from the Japanese Intensive Care PAtient Database (JIPAD) from April 2015 to March 2021, this retrospective cohort study was conducted in 80 ICUs across Japan and included 72,214 emergency patients aged ≥ 16 years. The primary outcome measure was in-hospital mortality, and the secondary outcomes encompassed ICU mortality, 28-day mortality, ventilator-free days, and the lengths of ICU and hospital stays. Bayesian hierarchical generalized linear mixed models were used to adjust for patient- and ICU-level variables.

Results: This study revealed a significant association between a higher ICU case volume and decreased in-hospital mortality. In particular, ICUs with a higher percentage (> 75%) of emergency patients showed more pronounced effects, with the odds ratios for in-hospital mortality in the higher case volume quartiles (Q2, Q3, and Q4) being 0.92 (95% credible interval [CI]: 0.88-0.96), 0.70 (95% CI: 0.67-0.73), and 0.78 (95% CI: 0.73-0.83), respectively, compared with the lowest quartile (Q1). Similar trends were observed for various secondary outcomes.

Conclusions: Higher ICU case volumes were significantly associated with lower in-hospital mortality rates in Japanese ICUs predominantly treating critically ill emergency patients. These findings emphasize the importance of ICU specialization and highlight the potential benefits of centralized care for critically ill emergency patients. These findings are potential insights for improving health care policy in Japan and may be valuable in emergency care settings in other countries with similar healthcare systems, after careful consideration of contextual differences.

背景:以往的研究探讨了败血症、创伤等危重病以及各种手术的病例数与患者预后之间的关系,认为病例数越多对患者预后越有利。本研究旨在阐明重症监护病房(ICU)病例量、专业化程度和急诊重症患者预后之间的关系,并确定重症监护病房病例量和专业化程度如何影响日本重症监护病房中这些患者的预后:这项回顾性队列研究利用日本重症监护患者数据库(JIPAD)2015 年 4 月至 2021 年 3 月的数据,在日本全国 80 个重症监护病房进行,共纳入 72214 名年龄≥ 16 岁的急诊患者。研究的主要结果是院内死亡率,次要结果包括重症监护室死亡率、28 天死亡率、无呼吸机天数以及重症监护室和住院时间。贝叶斯分层广义线性混合模型用于调整患者和重症监护室层面的变量:结果:这项研究显示,重症监护室病例量越大,院内死亡率越低。与最低四分位数(Q1)相比,病例量较高的四分位数(Q2、Q3和Q4)的院内死亡率的几率比分别为0.92(95%可信区间[CI]:0.88-0.96)、0.70(95% CI:0.67-0.73)和0.78(95% CI:0.73-0.83)。在各种次要结果中也观察到类似的趋势:结论:在主要治疗急诊重症患者的日本 ICU 中,ICU 病例量越大,院内死亡率越低。这些发现强调了重症监护室专业化的重要性,并凸显了对危重急症患者进行集中护理的潜在益处。这些研究结果对改善日本的医疗保健政策具有潜在的启示意义,在仔细考虑环境差异后,也可能对具有类似医疗保健系统的其他国家的急诊环境有价值。
{"title":"Case volume and specialization in critically ill emergency patients: a nationwide cohort study in Japanese ICUs.","authors":"Jun Fujinaga, Takanao Otake, Takehide Umeda, Toshio Fukuoka","doi":"10.1186/s40560-024-00733-3","DOIUrl":"10.1186/s40560-024-00733-3","url":null,"abstract":"<p><strong>Background: </strong>Previous studies have explored the association between the number of cases and patient outcomes for critical illnesses such as sepsis and trauma, as well as various surgeries, with the expectation that a higher number of cases would have a more favorable effect on patient outcomes. The aim of this study was to elucidate the association among intensive care unit (ICU) case volume, specialization, and patient outcomes in critically ill emergency patients and to determine how ICU case volumes and specializations impact the outcomes of these patients in Japanese ICUs.</p><p><strong>Methods: </strong>Utilizing data from the Japanese Intensive Care PAtient Database (JIPAD) from April 2015 to March 2021, this retrospective cohort study was conducted in 80 ICUs across Japan and included 72,214 emergency patients aged ≥ 16 years. The primary outcome measure was in-hospital mortality, and the secondary outcomes encompassed ICU mortality, 28-day mortality, ventilator-free days, and the lengths of ICU and hospital stays. Bayesian hierarchical generalized linear mixed models were used to adjust for patient- and ICU-level variables.</p><p><strong>Results: </strong>This study revealed a significant association between a higher ICU case volume and decreased in-hospital mortality. In particular, ICUs with a higher percentage (> 75%) of emergency patients showed more pronounced effects, with the odds ratios for in-hospital mortality in the higher case volume quartiles (Q2, Q3, and Q4) being 0.92 (95% credible interval [CI]: 0.88-0.96), 0.70 (95% CI: 0.67-0.73), and 0.78 (95% CI: 0.73-0.83), respectively, compared with the lowest quartile (Q1). Similar trends were observed for various secondary outcomes.</p><p><strong>Conclusions: </strong>Higher ICU case volumes were significantly associated with lower in-hospital mortality rates in Japanese ICUs predominantly treating critically ill emergency patients. These findings emphasize the importance of ICU specialization and highlight the potential benefits of centralized care for critically ill emergency patients. These findings are potential insights for improving health care policy in Japan and may be valuable in emergency care settings in other countries with similar healthcare systems, after careful consideration of contextual differences.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":"12 1","pages":"20"},"PeriodicalIF":7.1,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100151/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140957384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanisms maintaining right ventricular contractility-to-pulmonary arterial elastance ratio in VA ECMO: a retrospective animal data analysis of RV-PA coupling. 维持 VA ECMO 中右心室收缩力与肺动脉弹性比值的机制:RV-PA 耦合的回顾性动物数据分析。
IF 7.1 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-05-11 DOI: 10.1186/s40560-024-00730-6
Kaspar F Bachmann, Per Werner Moller, Lukas Hunziker, Marco Maggiorini, David Berger

Background: To optimize right ventricular-pulmonary coupling during veno-arterial (VA) ECMO weaning, inotropes, vasopressors and/or vasodilators are used to change right ventricular (RV) function (contractility) and pulmonary artery (PA) elastance (afterload). RV-PA coupling is the ratio between right ventricular contractility and pulmonary vascular elastance and as such, is a measure of optimized crosstalk between ventricle and vasculature. Little is known about the physiology of RV-PA coupling during VA ECMO. This study describes adaptive mechanisms for maintaining RV-PA coupling resulting from changing pre- and afterload conditions in VA ECMO.

Methods: In 13 pigs, extracorporeal flow was reduced from 4 to 1 L/min at baseline and increased afterload (pulmonary embolism and hypoxic vasoconstriction). Pressure and flow signals estimated right ventricular end-systolic elastance and pulmonary arterial elastance. Linear mixed-effect models estimated the association between conditions and elastance.

Results: At no extracorporeal flow, end-systolic elastance increased from 0.83 [0.66 to 1.00] mmHg/mL at baseline by 0.44 [0.29 to 0.59] mmHg/mL with pulmonary embolism and by 1.36 [1.21 to 1.51] mmHg/mL with hypoxic pulmonary vasoconstriction (p < 0.001). Pulmonary arterial elastance increased from 0.39 [0.30 to 0.49] mmHg/mL at baseline by 0.36 [0.27 to 0.44] mmHg/mL with pulmonary embolism and by 0.75 [0.67 to 0.84] mmHg/mL with hypoxic pulmonary vasoconstriction (p < 0.001). Coupling remained unchanged (2.1 [1.8 to 2.3] mmHg/mL at baseline; - 0.1 [- 0.3 to 0.1] mmHg/mL increase with pulmonary embolism; - 0.2 [- 0.4 to 0.0] mmHg/mL with hypoxic pulmonary vasoconstriction, p > 0.05). Extracorporeal flow did not change coupling (0.0 [- 0.0 to 0.1] per change of 1 L/min, p > 0.05). End-diastolic volume increased with decreasing extracorporeal flow (7.2 [6.6 to 7.8] ml change per 1 L/min, p < 0.001).

Conclusions: The right ventricle dilates with increased preload and increases its contractility in response to afterload changes to maintain ventricular-arterial coupling during VA extracorporeal membrane oxygenation.

背景:为了在静脉-动脉(VA)ECMO 断流期间优化右心室-肺耦合,使用了肌力剂、血管加压剂和/或血管扩张剂来改变右心室(RV)功能(收缩力)和肺动脉(PA)弹性(后负荷)。RV-PA 耦合是右心室收缩力和肺血管弹性之间的比率,因此是衡量心室和血管之间优化串扰的指标。人们对 VA ECMO 期间 RV-PA 耦合的生理学知之甚少。本研究描述了在 VA ECMO 中因前负荷和后负荷条件变化而导致的维持 RV-PA 耦合的适应性机制:方法:在 13 头猪中,将体外流量从基线时的 4 升/分钟降至 1 升/分钟,并增加后负荷(肺栓塞和缺氧性血管收缩)。压力和流量信号估算了右心室收缩末期弹性和肺动脉弹性。线性混合效应模型估计了条件与弹性之间的关联:结果:在没有体外血流的情况下,收缩末期弹性从基线时的 0.83 [0.66 至 1.00] mmHg/mL增加了 0.44 [0.29 至 0.59] mmHg/mL,肺栓塞时增加了 0.44 [0.29 至 0.59] mmHg/mL,缺氧性肺血管收缩时增加了 1.36 [1.21 至 1.51] mmHg/mL(P 0.05)。体外流量没有耦合变化(每变化 1 升/分钟,耦合变化为 0.0 [- 0.0 至 0.1],P > 0.05)。舒张末期容积随体外流量的减少而增加(每 1 升/分钟变化 7.2 [6.6 至 7.8] 毫升,p 结论:体外流量减少时,舒张末期容积增加(每 1 升/分钟变化 7.2 [6.6 至 7.8] 毫升,p):右心室随着前负荷的增加而扩张,并随着后负荷的变化而增加收缩力,以维持体外膜肺氧合过程中的心室-动脉耦合。
{"title":"Mechanisms maintaining right ventricular contractility-to-pulmonary arterial elastance ratio in VA ECMO: a retrospective animal data analysis of RV-PA coupling.","authors":"Kaspar F Bachmann, Per Werner Moller, Lukas Hunziker, Marco Maggiorini, David Berger","doi":"10.1186/s40560-024-00730-6","DOIUrl":"10.1186/s40560-024-00730-6","url":null,"abstract":"<p><strong>Background: </strong>To optimize right ventricular-pulmonary coupling during veno-arterial (VA) ECMO weaning, inotropes, vasopressors and/or vasodilators are used to change right ventricular (RV) function (contractility) and pulmonary artery (PA) elastance (afterload). RV-PA coupling is the ratio between right ventricular contractility and pulmonary vascular elastance and as such, is a measure of optimized crosstalk between ventricle and vasculature. Little is known about the physiology of RV-PA coupling during VA ECMO. This study describes adaptive mechanisms for maintaining RV-PA coupling resulting from changing pre- and afterload conditions in VA ECMO.</p><p><strong>Methods: </strong>In 13 pigs, extracorporeal flow was reduced from 4 to 1 L/min at baseline and increased afterload (pulmonary embolism and hypoxic vasoconstriction). Pressure and flow signals estimated right ventricular end-systolic elastance and pulmonary arterial elastance. Linear mixed-effect models estimated the association between conditions and elastance.</p><p><strong>Results: </strong>At no extracorporeal flow, end-systolic elastance increased from 0.83 [0.66 to 1.00] mmHg/mL at baseline by 0.44 [0.29 to 0.59] mmHg/mL with pulmonary embolism and by 1.36 [1.21 to 1.51] mmHg/mL with hypoxic pulmonary vasoconstriction (p < 0.001). Pulmonary arterial elastance increased from 0.39 [0.30 to 0.49] mmHg/mL at baseline by 0.36 [0.27 to 0.44] mmHg/mL with pulmonary embolism and by 0.75 [0.67 to 0.84] mmHg/mL with hypoxic pulmonary vasoconstriction (p < 0.001). Coupling remained unchanged (2.1 [1.8 to 2.3] mmHg/mL at baseline; - 0.1 [- 0.3 to 0.1] mmHg/mL increase with pulmonary embolism; - 0.2 [- 0.4 to 0.0] mmHg/mL with hypoxic pulmonary vasoconstriction, p > 0.05). Extracorporeal flow did not change coupling (0.0 [- 0.0 to 0.1] per change of 1 L/min, p > 0.05). End-diastolic volume increased with decreasing extracorporeal flow (7.2 [6.6 to 7.8] ml change per 1 L/min, p < 0.001).</p><p><strong>Conclusions: </strong>The right ventricle dilates with increased preload and increases its contractility in response to afterload changes to maintain ventricular-arterial coupling during VA extracorporeal membrane oxygenation.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":"12 1","pages":"19"},"PeriodicalIF":7.1,"publicationDate":"2024-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11088130/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140908929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemorrhage and thrombosis in COVID-19-patients supported with extracorporeal membrane oxygenation: an international study based on the COVID-19 critical care consortium. 使用体外膜氧合的 COVID-19 患者的出血和血栓形成:基于 COVID-19 重症监护联盟的国际研究。
IF 3.8 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-05-06 DOI: 10.1186/s40560-024-00726-2
Maximilian Feth, Natasha Weaver, Robert B Fanning, Sung-Min Cho, Matthew J Griffee, Mauro Panigada, Akram M Zaaqoq, Ahmed Labib, Glenn J R Whitman, Rakesh C Arora, Bo S Kim, Nicole White, Jacky Y Suen, Gianluigi Li Bassi, Giles J Peek, Roberto Lorusso, Heidi Dalton, John F Fraser, Jonathon P Fanning

Background: Extracorporeal membrane oxygenation (ECMO) is a rescue therapy in patients with severe acute respiratory distress syndrome (ARDS) secondary to COVID-19. While bleeding and thrombosis complicate ECMO, these events may also occur secondary to COVID-19. Data regarding bleeding and thrombotic events in COVID-19 patients on ECMO are sparse.

Methods: Using the COVID-19 Critical Care Consortium database, we conducted a retrospective analysis on adult patients with severe COVID-19 requiring ECMO, including centers globally from 01/2020 to 06/2022, to determine the risk of ICU mortality associated with the occurrence of bleeding and clotting disorders.

Results: Among 1,248 COVID-19 patients receiving ECMO support in the registry, coagulation complications were reported in 469 cases (38%), among whom 252 (54%) experienced hemorrhagic complications, 165 (35%) thrombotic complications, and 52 (11%) both. The hazard ratio (HR) for Intensive Care Unit mortality was higher in those with hemorrhagic-only complications than those with neither complication (adjusted HR = 1.60, 95% CI 1.28-1.99, p < 0.001). Death was reported in 617 of the 1248 (49.4%) with multiorgan failure (n = 257 of 617 [42%]), followed by respiratory failure (n = 130 of 617 [21%]) and septic shock [n = 55 of 617 (8.9%)] the leading causes.

Conclusions: Coagulation disorders are frequent in COVID-19 ARDS patients receiving ECMO. Bleeding events contribute substantially to mortality in this cohort. However, this risk may be lower than previously reported in single-nation studies or early case reports. Trial registration ACTRN12620000421932 ( https://covid19.cochrane.org/studies/crs-13513201 ).

背景:体外膜肺氧合(ECMO)是继发于 COVID-19 的严重急性呼吸窘迫综合征(ARDS)患者的一种抢救疗法。出血和血栓形成是 ECMO 的并发症,这些事件也可能继发于 COVID-19。有关 COVID-19 患者在 ECMO 中发生出血和血栓事件的数据很少:我们利用 COVID-19 重症监护联盟数据库,对 2020 年 1 月 1 日至 2022 年 6 月 6 日期间全球各中心需要 ECMO 的重症 COVID-19 成人患者进行了回顾性分析,以确定与出血和凝血障碍发生相关的 ICU 死亡率风险:在登记的 1248 例接受 ECMO 支持的 COVID-19 患者中,有 469 例(38%)报告出现凝血并发症,其中 252 例(54%)出现出血性并发症,165 例(35%)出现血栓性并发症,52 例(11%)同时出现出血性和血栓性并发症。仅有出血并发症者的重症监护室死亡率危险比(HR)高于无出血并发症者(调整后的HR = 1.60,95% CI 1.28-1.99,P 结论:凝血功能障碍是一种常见的并发症:接受 ECMO 的 COVID-19 ARDS 患者经常出现凝血功能障碍。出血事件大大增加了该组患者的死亡率。然而,这一风险可能低于之前单个国家的研究或早期病例报告。试验注册 ACTRN12620000421932 ( https://covid19.cochrane.org/studies/crs-13513201 )。
{"title":"Hemorrhage and thrombosis in COVID-19-patients supported with extracorporeal membrane oxygenation: an international study based on the COVID-19 critical care consortium.","authors":"Maximilian Feth, Natasha Weaver, Robert B Fanning, Sung-Min Cho, Matthew J Griffee, Mauro Panigada, Akram M Zaaqoq, Ahmed Labib, Glenn J R Whitman, Rakesh C Arora, Bo S Kim, Nicole White, Jacky Y Suen, Gianluigi Li Bassi, Giles J Peek, Roberto Lorusso, Heidi Dalton, John F Fraser, Jonathon P Fanning","doi":"10.1186/s40560-024-00726-2","DOIUrl":"10.1186/s40560-024-00726-2","url":null,"abstract":"<p><strong>Background: </strong>Extracorporeal membrane oxygenation (ECMO) is a rescue therapy in patients with severe acute respiratory distress syndrome (ARDS) secondary to COVID-19. While bleeding and thrombosis complicate ECMO, these events may also occur secondary to COVID-19. Data regarding bleeding and thrombotic events in COVID-19 patients on ECMO are sparse.</p><p><strong>Methods: </strong>Using the COVID-19 Critical Care Consortium database, we conducted a retrospective analysis on adult patients with severe COVID-19 requiring ECMO, including centers globally from 01/2020 to 06/2022, to determine the risk of ICU mortality associated with the occurrence of bleeding and clotting disorders.</p><p><strong>Results: </strong>Among 1,248 COVID-19 patients receiving ECMO support in the registry, coagulation complications were reported in 469 cases (38%), among whom 252 (54%) experienced hemorrhagic complications, 165 (35%) thrombotic complications, and 52 (11%) both. The hazard ratio (HR) for Intensive Care Unit mortality was higher in those with hemorrhagic-only complications than those with neither complication (adjusted HR = 1.60, 95% CI 1.28-1.99, p < 0.001). Death was reported in 617 of the 1248 (49.4%) with multiorgan failure (n = 257 of 617 [42%]), followed by respiratory failure (n = 130 of 617 [21%]) and septic shock [n = 55 of 617 (8.9%)] the leading causes.</p><p><strong>Conclusions: </strong>Coagulation disorders are frequent in COVID-19 ARDS patients receiving ECMO. Bleeding events contribute substantially to mortality in this cohort. However, this risk may be lower than previously reported in single-nation studies or early case reports. Trial registration ACTRN12620000421932 ( https://covid19.cochrane.org/studies/crs-13513201 ).</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":"12 1","pages":"18"},"PeriodicalIF":3.8,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11071263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140850957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in cardiorespiratory monitoring in acute respiratory distress syndrome patients 急性呼吸窘迫综合征患者心肺监测的最新进展
IF 7.1 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-05-05 DOI: 10.1186/s40560-024-00727-1
Davide Chiumello, Antonio Fioccola
Recent advances on cardiorespiratory monitoring applied in ARDS patients undergoing invasive mechanical ventilation and noninvasive ventilatory support are available in the literature and may have potential prognostic implication in ARDS treatment. The measurement of oxygen saturation by pulse oximetry is a valid, low-cost, noninvasive alternative for assessing arterial oxygenation. Caution must be taken in patients with darker skin pigmentation, who may experience a greater incidence of occult hypoxemia. Dead space surrogates, which are easy to calculate, have important prognostic implications. The mechanical power, which can be automatically computed by intensive care ventilators, is an important parameter correlated with ventilator-induced lung injury and outcome. In patients undergoing noninvasive ventilatory support, the use of esophageal pressure can measure inspiratory effort, avoiding possible delays in endotracheal intubation. Fluid responsiveness can also be evaluated using dynamic indices in patients ventilated at low tidal volumes (< 8 mL/kg). In patients ventilated at high levels of positive end expiratory pressure (PEEP), the PEEP test represents a valid alternative to passive leg raising. There is growing evidence on alternative parameters for evaluating fluid responsiveness, such as central venous oxygen saturation variations, inferior vena cava diameter variations and capillary refill time. Careful cardiorespiratory monitoring in patients affected by ARDS is crucial to improve prognosis and to tailor treatment via mechanical ventilatory support.
文献报道了对接受有创机械通气和无创通气支持的 ARDS 患者进行心肺监测的最新进展,这些进展可能对 ARDS 的治疗具有潜在的预后意义。用脉搏血氧仪测量血氧饱和度是评估动脉氧饱和度的一种有效、低成本、无创的替代方法。对于皮肤色素较深的患者必须谨慎,因为他们可能会出现更多的隐性低氧血症。死腔替代物易于计算,对预后有重要影响。重症监护呼吸机可自动计算机械功率,这是一个与呼吸机诱发的肺损伤和预后相关的重要参数。在接受无创通气支持的患者中,使用食管压力可以测量吸气力度,避免气管插管可能出现的延误。在低潮气量(< 8 mL/kg)通气的患者中,也可使用动态指数评估液体反应性。对于呼气末正压(PEEP)水平较高的通气患者,PEEP 测试是被动抬腿的有效替代方法。越来越多的证据表明,有其他参数可用于评估输液反应性,如中心静脉血氧饱和度变化、下腔静脉直径变化和毛细血管再充盈时间。对 ARDS 患者进行仔细的心肺监测对于改善预后和通过机械通气支持进行针对性治疗至关重要。
{"title":"Recent advances in cardiorespiratory monitoring in acute respiratory distress syndrome patients","authors":"Davide Chiumello, Antonio Fioccola","doi":"10.1186/s40560-024-00727-1","DOIUrl":"https://doi.org/10.1186/s40560-024-00727-1","url":null,"abstract":"Recent advances on cardiorespiratory monitoring applied in ARDS patients undergoing invasive mechanical ventilation and noninvasive ventilatory support are available in the literature and may have potential prognostic implication in ARDS treatment. The measurement of oxygen saturation by pulse oximetry is a valid, low-cost, noninvasive alternative for assessing arterial oxygenation. Caution must be taken in patients with darker skin pigmentation, who may experience a greater incidence of occult hypoxemia. Dead space surrogates, which are easy to calculate, have important prognostic implications. The mechanical power, which can be automatically computed by intensive care ventilators, is an important parameter correlated with ventilator-induced lung injury and outcome. In patients undergoing noninvasive ventilatory support, the use of esophageal pressure can measure inspiratory effort, avoiding possible delays in endotracheal intubation. Fluid responsiveness can also be evaluated using dynamic indices in patients ventilated at low tidal volumes (< 8 mL/kg). In patients ventilated at high levels of positive end expiratory pressure (PEEP), the PEEP test represents a valid alternative to passive leg raising. There is growing evidence on alternative parameters for evaluating fluid responsiveness, such as central venous oxygen saturation variations, inferior vena cava diameter variations and capillary refill time. Careful cardiorespiratory monitoring in patients affected by ARDS is crucial to improve prognosis and to tailor treatment via mechanical ventilatory support. ","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":"1 1","pages":""},"PeriodicalIF":7.1,"publicationDate":"2024-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140827414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic nutritional index as a predictive marker for acute kidney injury in adult critical illness population: a systematic review and diagnostic test accuracy meta-analysis 预后营养指数作为成人危重病人群急性肾损伤的预测指标:系统综述和诊断测试准确性荟萃分析
IF 7.1 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-04-26 DOI: 10.1186/s40560-024-00729-z
Jia-Jin Chen, Tao-Han Lee, Pei-Chun Lai, Chih-Hsiang Chang, Che-Hsiung Wu, Yen-Ta Huang
The prognostic nutritional index (PNI), integrating nutrition and inflammation markers, has been increasingly recognized as a prognostic predictor in diverse patient cohorts. Recently, its effectiveness as a predictive marker for acute kidney injury (AKI) in various clinical settings has gained attention. This study aims to assess the predictive accuracy of the PNI for AKI in critically ill populations through systematic review and meta-analysis. A systematic review was conducted using the databases MEDLINE, EMBASE, PubMed, and China National Knowledge Infrastructure up to August 2023. The included trials reported the PNI assessment in adult population with critical illness and its predictive capacity for AKI. Data on study characteristics, subgroup covariates, and diagnostic performance of PNI, including sensitivity, specificity, and event rates, were extracted. A diagnostic test accuracy meta-analysis was performed. Subgroup analyses and meta-regression were utilized to investigate the sources of heterogeneity. The GRADE framework evaluated the confidence in the meta-analysis’s evidence. The analysis encompassed 16 studies with 17 separate cohorts, totaling 21,239 patients. The pooled sensitivity and specificity of PNI for AKI prediction were 0.67 (95% CI 0.58–0.74) and 0.74 (95% CI 0.67–0.80), respectively. The pooled positive likelihood ratio was 2.49 (95% CI 1.99–3.11; low certainty), and the negative likelihood ratio was 0.46 (95% CI 0.37–0.56; low certainty). The pooled diagnostic odds ratio was 5.54 (95% CI 3.80–8.07), with an area under curve of summary receiver operating characteristics of 0.76. Subgroup analysis showed that PNI’s sensitivity was higher in medical populations than in surgical populations (0.72 vs. 0.55; p < 0.05) and in studies excluding patients with chronic kidney disease (CKD) than in those including them (0.75 vs. 0.56; p < 0.01). Overall, diagnostic performance was superior in the non-chronic kidney disease group. Our study demonstrated that PNI has practical accuracy for predicting the development of AKI in critically ill populations, with superior diagnostic performance observed in medical and non-CKD populations. However, the diagnostic efficacy of the PNI has significant heterogeneity with different cutoff value, indicating the need for further research.
预后营养指数(PNI)综合了营养和炎症指标,已被越来越多的人认为是不同患者群体的预后预测指标。最近,该指数作为急性肾损伤(AKI)的预测指标在各种临床环境中的有效性受到了关注。本研究旨在通过系统综述和荟萃分析评估 PNI 对重症患者 AKI 的预测准确性。本研究利用截至 2023 年 8 月的 MEDLINE、EMBASE、PubMed 和中国知网等数据库进行了系统综述。纳入的试验报告了成人危重症患者的 PNI 评估及其对 AKI 的预测能力。研究提取了有关研究特征、亚组协变量和 PNI 诊断性能(包括敏感性、特异性和事件发生率)的数据。进行了诊断测试准确性荟萃分析。利用亚组分析和元回归研究异质性的来源。GRADE 框架评估了荟萃分析证据的可信度。该分析包括16项研究,17个独立队列,共计21239名患者。PNI 预测 AKI 的汇总灵敏度和特异度分别为 0.67(95% CI 0.58-0.74)和 0.74(95% CI 0.67-0.80)。汇总的阳性似然比为 2.49(95% CI 1.99-3.11;低确定性),阴性似然比为 0.46(95% CI 0.37-0.56;低确定性)。汇总诊断几率比为 5.54(95% CI 3.80-8.07),汇总接收者操作特征曲线下面积为 0.76。亚组分析显示,PNI 的灵敏度在内科人群中高于外科人群(0.72 vs. 0.55;P < 0.05),在不包括慢性肾病 (CKD) 患者的研究中高于包括慢性肾病患者的研究(0.75 vs. 0.56;P < 0.01)。总体而言,非慢性肾脏病组的诊断效果更好。我们的研究表明,PNI 在预测危重病人发生 AKI 方面具有实用的准确性,在内科和非慢性肾脏病人群中的诊断效果更佳。然而,随着截断值的不同,PNI 的诊断效果也存在显著的异质性,这表明还需要进一步的研究。
{"title":"Prognostic nutritional index as a predictive marker for acute kidney injury in adult critical illness population: a systematic review and diagnostic test accuracy meta-analysis","authors":"Jia-Jin Chen, Tao-Han Lee, Pei-Chun Lai, Chih-Hsiang Chang, Che-Hsiung Wu, Yen-Ta Huang","doi":"10.1186/s40560-024-00729-z","DOIUrl":"https://doi.org/10.1186/s40560-024-00729-z","url":null,"abstract":"The prognostic nutritional index (PNI), integrating nutrition and inflammation markers, has been increasingly recognized as a prognostic predictor in diverse patient cohorts. Recently, its effectiveness as a predictive marker for acute kidney injury (AKI) in various clinical settings has gained attention. This study aims to assess the predictive accuracy of the PNI for AKI in critically ill populations through systematic review and meta-analysis. A systematic review was conducted using the databases MEDLINE, EMBASE, PubMed, and China National Knowledge Infrastructure up to August 2023. The included trials reported the PNI assessment in adult population with critical illness and its predictive capacity for AKI. Data on study characteristics, subgroup covariates, and diagnostic performance of PNI, including sensitivity, specificity, and event rates, were extracted. A diagnostic test accuracy meta-analysis was performed. Subgroup analyses and meta-regression were utilized to investigate the sources of heterogeneity. The GRADE framework evaluated the confidence in the meta-analysis’s evidence. The analysis encompassed 16 studies with 17 separate cohorts, totaling 21,239 patients. The pooled sensitivity and specificity of PNI for AKI prediction were 0.67 (95% CI 0.58–0.74) and 0.74 (95% CI 0.67–0.80), respectively. The pooled positive likelihood ratio was 2.49 (95% CI 1.99–3.11; low certainty), and the negative likelihood ratio was 0.46 (95% CI 0.37–0.56; low certainty). The pooled diagnostic odds ratio was 5.54 (95% CI 3.80–8.07), with an area under curve of summary receiver operating characteristics of 0.76. Subgroup analysis showed that PNI’s sensitivity was higher in medical populations than in surgical populations (0.72 vs. 0.55; p < 0.05) and in studies excluding patients with chronic kidney disease (CKD) than in those including them (0.75 vs. 0.56; p < 0.01). Overall, diagnostic performance was superior in the non-chronic kidney disease group. Our study demonstrated that PNI has practical accuracy for predicting the development of AKI in critically ill populations, with superior diagnostic performance observed in medical and non-CKD populations. However, the diagnostic efficacy of the PNI has significant heterogeneity with different cutoff value, indicating the need for further research.","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":"11 1","pages":""},"PeriodicalIF":7.1,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140798433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respiratory drive: a journey from health to disease 呼吸驱动:从健康到疾病的旅程
IF 7.1 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-04-22 DOI: 10.1186/s40560-024-00731-5
Dimitrios Georgopoulos, Maria Bolaki, Vaia Stamatopoulou, Evangelia Akoumianaki
Respiratory drive is defined as the intensity of respiratory centers output during the breath and is primarily affected by cortical and chemical feedback mechanisms. During the involuntary act of breathing, chemical feedback, primarily mediated through CO2, is the main determinant of respiratory drive. Respiratory drive travels through neural pathways to respiratory muscles, which execute the breathing process and generate inspiratory flow (inspiratory flow-generation pathway). In a healthy state, inspiratory flow-generation pathway is intact, and thus respiratory drive is satisfied by the rate of volume increase, expressed by mean inspiratory flow, which in turn determines tidal volume. In this review, we will explain the pathophysiology of altered respiratory drive by analyzing the respiratory centers response to arterial partial pressure of CO2 (PaCO2) changes. Both high and low respiratory drive have been associated with several adverse effects in critically ill patients. Hence, it is crucial to understand what alters the respiratory drive. Changes in respiratory drive can be explained by simultaneously considering the (1) ventilatory demands, as dictated by respiratory centers activity to CO2 (brain curve); (2) actual ventilatory response to CO2 (ventilation curve); and (3) metabolic hyperbola. During critical illness, multiple mechanisms affect the brain and ventilation curves, as well as metabolic hyperbola, leading to considerable alterations in respiratory drive. In critically ill patients the inspiratory flow-generation pathway is invariably compromised at various levels. Consequently, mean inspiratory flow and tidal volume do not correspond to respiratory drive, and at a given PaCO2, the actual ventilation is less than ventilatory demands, creating a dissociation between brain and ventilation curves. Since the metabolic hyperbola is one of the two variables that determine PaCO2 (the other being the ventilation curve), its upward or downward movements increase or decrease respiratory drive, respectively. Mechanical ventilation indirectly influences respiratory drive by modifying PaCO2 levels through alterations in various parameters of the ventilation curve and metabolic hyperbola. Understanding the diverse factors that modulate respiratory drive at the bedside could enhance clinical assessment and the management of both the patient and the ventilator.
呼吸驱动力是指呼吸过程中呼吸中枢输出的强度,主要受大脑皮层和化学反馈机制的影响。在非自主呼吸过程中,主要通过二氧化碳介导的化学反馈是呼吸驱动力的主要决定因素。呼吸驱动力通过神经通路到达呼吸肌,呼吸肌执行呼吸过程并产生吸气流量(吸气流量产生通路)。在健康状态下,吸气流量产生途径是完好的,因此呼吸驱动力由体积增加率来满足,体积增加率由平均吸气流量来表示,而平均吸气流量又决定了潮气量。在本综述中,我们将通过分析呼吸中枢对动脉二氧化碳分压(PaCO2)变化的反应来解释呼吸驱动力改变的病理生理学。呼吸驱动力过高和过低都与危重病人的多种不良反应有关。因此,了解是什么改变了呼吸驱动力至关重要。呼吸驱动力的变化可通过同时考虑以下因素来解释:(1)呼吸中枢活动对二氧化碳的通气需求(脑曲线);(2)对二氧化碳的实际通气反应(通气曲线);以及(3)代谢双曲线。危重病人的大脑和通气曲线以及代谢双曲线会受到多种机制的影响,从而导致呼吸驱动力发生巨大变化。危重病人的吸气流量生成途径总会受到不同程度的影响。因此,平均吸气流量和潮气量与呼吸驱动力不一致,在给定的 PaCO2 条件下,实际通气量小于通气需求量,从而导致脑部曲线与通气曲线之间出现分离。由于代谢双曲线是决定 PaCO2 的两个变量之一(另一个是通气曲线),其向上或向下移动会分别增加或减少呼吸驱动力。机械通气通过改变通气曲线和代谢双曲线的各种参数来调节 PaCO2 水平,从而间接影响呼吸驱动力。了解床旁调节呼吸驱动力的各种因素可加强临床评估以及对患者和呼吸机的管理。
{"title":"Respiratory drive: a journey from health to disease","authors":"Dimitrios Georgopoulos, Maria Bolaki, Vaia Stamatopoulou, Evangelia Akoumianaki","doi":"10.1186/s40560-024-00731-5","DOIUrl":"https://doi.org/10.1186/s40560-024-00731-5","url":null,"abstract":"Respiratory drive is defined as the intensity of respiratory centers output during the breath and is primarily affected by cortical and chemical feedback mechanisms. During the involuntary act of breathing, chemical feedback, primarily mediated through CO2, is the main determinant of respiratory drive. Respiratory drive travels through neural pathways to respiratory muscles, which execute the breathing process and generate inspiratory flow (inspiratory flow-generation pathway). In a healthy state, inspiratory flow-generation pathway is intact, and thus respiratory drive is satisfied by the rate of volume increase, expressed by mean inspiratory flow, which in turn determines tidal volume. In this review, we will explain the pathophysiology of altered respiratory drive by analyzing the respiratory centers response to arterial partial pressure of CO2 (PaCO2) changes. Both high and low respiratory drive have been associated with several adverse effects in critically ill patients. Hence, it is crucial to understand what alters the respiratory drive. Changes in respiratory drive can be explained by simultaneously considering the (1) ventilatory demands, as dictated by respiratory centers activity to CO2 (brain curve); (2) actual ventilatory response to CO2 (ventilation curve); and (3) metabolic hyperbola. During critical illness, multiple mechanisms affect the brain and ventilation curves, as well as metabolic hyperbola, leading to considerable alterations in respiratory drive. In critically ill patients the inspiratory flow-generation pathway is invariably compromised at various levels. Consequently, mean inspiratory flow and tidal volume do not correspond to respiratory drive, and at a given PaCO2, the actual ventilation is less than ventilatory demands, creating a dissociation between brain and ventilation curves. Since the metabolic hyperbola is one of the two variables that determine PaCO2 (the other being the ventilation curve), its upward or downward movements increase or decrease respiratory drive, respectively. Mechanical ventilation indirectly influences respiratory drive by modifying PaCO2 levels through alterations in various parameters of the ventilation curve and metabolic hyperbola. Understanding the diverse factors that modulate respiratory drive at the bedside could enhance clinical assessment and the management of both the patient and the ventilator.","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":"33 1","pages":""},"PeriodicalIF":7.1,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140634367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The optimal glycemic target in critically ill patients: an updated network meta-analysis 重症患者的最佳血糖目标:最新网络荟萃分析
IF 7.1 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-04-14 DOI: 10.1186/s40560-024-00728-0
Aiko Tanaka, Tomoaki Yatabe, Tomohiro Suhara, Moritoki Egi
Acute glycemic control significantly affects the clinical outcomes of critically ill patients. This updated network meta-analysis examines the benefits and harms of four target blood glucose levels (< 110, 110–144, 144–180, and > 180 mg/dL). Analyzing data of 27,541 patients from 37 trials, the surface under the cumulative ranking curve for mortality and hypoglycemia was highest at a target blood glucose level of 144–180 mg/dL, while for infection and acute kidney injury at 110–144 mg/dL. Further evidence is needed to determine whether 110–144 or 144–180 mg/dL is superior as an optimal glucose target, considering prioritized outcomes.
急性血糖控制对重症患者的临床疗效有重大影响。这项最新的网络荟萃分析研究了四种目标血糖水平(180 毫克/分升)的利弊。通过分析 37 项试验中 27,541 名患者的数据,死亡率和低血糖的累积排名曲线下表面值在目标血糖水平为 144-180 毫克/分升时最高,而感染和急性肾损伤的累积排名曲线下表面值在 110-144 毫克/分升时最高。考虑到优先考虑的结果,还需要进一步的证据来确定 110-144 或 144-180 毫克/分升作为最佳血糖目标值是否更优。
{"title":"The optimal glycemic target in critically ill patients: an updated network meta-analysis","authors":"Aiko Tanaka, Tomoaki Yatabe, Tomohiro Suhara, Moritoki Egi","doi":"10.1186/s40560-024-00728-0","DOIUrl":"https://doi.org/10.1186/s40560-024-00728-0","url":null,"abstract":"Acute glycemic control significantly affects the clinical outcomes of critically ill patients. This updated network meta-analysis examines the benefits and harms of four target blood glucose levels (< 110, 110–144, 144–180, and > 180 mg/dL). Analyzing data of 27,541 patients from 37 trials, the surface under the cumulative ranking curve for mortality and hypoglycemia was highest at a target blood glucose level of 144–180 mg/dL, while for infection and acute kidney injury at 110–144 mg/dL. Further evidence is needed to determine whether 110–144 or 144–180 mg/dL is superior as an optimal glucose target, considering prioritized outcomes.","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":"51 1","pages":""},"PeriodicalIF":7.1,"publicationDate":"2024-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140565262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors and outcomes of withholding and withdrawal of life-sustaining treatments in intensive care units in Singapore: a multicentre observational study. 新加坡重症监护病房暂停和撤销维持生命治疗的预测因素和结果:一项多中心观察研究。
IF 7.1 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-03-26 DOI: 10.1186/s40560-024-00725-3
Clare Fong, Wern Lunn Kueh, Sennen Jin Wen Lew, Benjamin Choon Heng Ho, Yu-Lin Wong, Yie Hui Lau, Yew Woon Chia, Hui Ling Tan, Ying Hao Christopher Seet, Wen Ting Siow, Graeme MacLaren, Rohit Agrawal, Tian Jin Lim, Shir Lynn Lim, Toon Wei Lim, Vui Kian Ho, Chai Rick Soh, Duu Wen Sewa, Chian Min Loo, Faheem Ahmed Khan, Chee Keat Tan, Roshni Sadashiv Gokhale, Chuin Siau, Noelle Louise Siew Hua Lim, Chik-Foo Yim, Jonathen Venkatachalam, Kumaresh Venkatesan, Naville Chi Hock Chia, Mei Fong Liew, Guihong Li, Li Li, Su Mon Myat, Zena Zena, Shuling Zhuo, Ling Ling Yueh, Caroline Shu Fang Tan, Jing Ma, Siew Lian Yeo, Yiong Huak Chan, Jason Phua

Background: Clinical practice guidelines on limitation of life-sustaining treatments (LST) in the intensive care unit (ICU), in the form of withholding or withdrawal of LST, state that there is no ethical difference between the two. Such statements are not uniformly accepted worldwide, and there are few studies on LST limitation in Asia. This study aimed to evaluate the predictors and outcomes of withholding and withdrawal of LST in Singapore, focusing on the similarities and differences between the two approaches.

Methods: This was a multicentre observational study of patients admitted to 21 adult ICUs across 9 public hospitals in Singapore over an average of three months per year from 2014 to 2019. The primary outcome measures were withholding and withdrawal of LST (cardiopulmonary resuscitation, invasive mechanical ventilation, and vasopressors/inotropes). The secondary outcome measure was hospital mortality. Multivariable generalised mixed model analysis was used to identify independent predictors for withdrawal and withholding of LST and if LST limitation predicts hospital mortality.

Results: There were 8907 patients and 9723 admissions. Of the former, 80.8% had no limitation of LST, 13.0% had LST withheld, and 6.2% had LST withdrawn. Common independent predictors for withholding and withdrawal were increasing age, absence of chronic kidney dialysis, greater dependence in activities of daily living, cardiopulmonary resuscitation before ICU admission, higher Acute Physiology and Chronic Health Evaluation (APACHE) II score, and higher level of care in the first 24 h of ICU admission. Additional predictors for withholding included being of Chinese race, the religions of Hinduism and Islam, malignancy, and chronic liver failure. The additional predictor for withdrawal was lower hospital paying class (with greater government subsidy for hospital bills). Hospital mortality in patients without LST limitation, with LST withholding, and with LST withdrawal was 10.6%, 82.1%, and 91.8%, respectively (p < 0.001). Withholding (odds ratio 13.822, 95% confidence interval 9.987-19.132) and withdrawal (odds ratio 38.319, 95% confidence interval 24.351-60.298) were both found to be independent predictors of hospital mortality on multivariable analysis.

Conclusions: Differences in the independent predictors of withholding and withdrawal of LST exist. Even after accounting for baseline characteristics, both withholding and withdrawal of LST independently predict hospital mortality. Later mortality in patients who had LST withdrawn compared to withholding suggests that the decision to withdraw may be at the point when medical futility is recognised.

背景:重症监护病房(ICU)限制维持生命治疗(LST)的临床实践指南指出,暂停或撤消 LST 在伦理上并无区别。这种说法在世界范围内并未得到一致认可,而亚洲关于 LST 限制的研究也很少。本研究旨在评估新加坡暂停和撤消 LST 的预测因素和结果,重点关注两种方法的异同:这是一项多中心观察性研究,研究对象是新加坡 9 家公立医院 21 个成人重症监护病房的住院患者,研究时间为 2014 年至 2019 年,平均每年三个月。主要结果指标是暂停和撤消LST(心肺复苏、有创机械通气和血管加压素/肌注)。次要结果指标为住院死亡率。采用多变量广义混合模型分析来确定撤除和暂停 LST 的独立预测因素,以及 LST 限制是否可预测住院死亡率:结果:共有 8907 名患者和 9723 次住院。在前者中,80.8%的患者未限制 LST,13.0%的患者暂停 LST,6.2%的患者撤回 LST。诱发暂停和撤消LST的常见独立预测因素包括:年龄增大、无慢性肾透析、日常生活活动依赖性较强、入ICU前进行过心肺复苏、急性生理学和慢性健康评估(APACHE)II评分较高以及入ICU后24小时内护理水平较高。其他可预测暂停治疗的因素包括华裔、印度教和伊斯兰教、恶性肿瘤和慢性肝功能衰竭。另一个预测放弃治疗的因素是医院支付等级较低(政府对医院账单的补贴较多)。无 LST 限制、暂停 LST 和撤消 LST 的患者的住院死亡率分别为 10.6%、82.1% 和 91.8%(P 结论:LST 限制和撤消 LST 的独立预测因素存在差异:暂停和撤消 LST 的独立预测因素存在差异。即使考虑了基线特征,暂停和撤消 LST 仍可独立预测住院死亡率。与暂停相比,撤消 LST 的患者死亡率较高,这表明撤消 LST 的决定可能是在认识到医疗无效的情况下做出的。
{"title":"Predictors and outcomes of withholding and withdrawal of life-sustaining treatments in intensive care units in Singapore: a multicentre observational study.","authors":"Clare Fong, Wern Lunn Kueh, Sennen Jin Wen Lew, Benjamin Choon Heng Ho, Yu-Lin Wong, Yie Hui Lau, Yew Woon Chia, Hui Ling Tan, Ying Hao Christopher Seet, Wen Ting Siow, Graeme MacLaren, Rohit Agrawal, Tian Jin Lim, Shir Lynn Lim, Toon Wei Lim, Vui Kian Ho, Chai Rick Soh, Duu Wen Sewa, Chian Min Loo, Faheem Ahmed Khan, Chee Keat Tan, Roshni Sadashiv Gokhale, Chuin Siau, Noelle Louise Siew Hua Lim, Chik-Foo Yim, Jonathen Venkatachalam, Kumaresh Venkatesan, Naville Chi Hock Chia, Mei Fong Liew, Guihong Li, Li Li, Su Mon Myat, Zena Zena, Shuling Zhuo, Ling Ling Yueh, Caroline Shu Fang Tan, Jing Ma, Siew Lian Yeo, Yiong Huak Chan, Jason Phua","doi":"10.1186/s40560-024-00725-3","DOIUrl":"10.1186/s40560-024-00725-3","url":null,"abstract":"<p><strong>Background: </strong>Clinical practice guidelines on limitation of life-sustaining treatments (LST) in the intensive care unit (ICU), in the form of withholding or withdrawal of LST, state that there is no ethical difference between the two. Such statements are not uniformly accepted worldwide, and there are few studies on LST limitation in Asia. This study aimed to evaluate the predictors and outcomes of withholding and withdrawal of LST in Singapore, focusing on the similarities and differences between the two approaches.</p><p><strong>Methods: </strong>This was a multicentre observational study of patients admitted to 21 adult ICUs across 9 public hospitals in Singapore over an average of three months per year from 2014 to 2019. The primary outcome measures were withholding and withdrawal of LST (cardiopulmonary resuscitation, invasive mechanical ventilation, and vasopressors/inotropes). The secondary outcome measure was hospital mortality. Multivariable generalised mixed model analysis was used to identify independent predictors for withdrawal and withholding of LST and if LST limitation predicts hospital mortality.</p><p><strong>Results: </strong>There were 8907 patients and 9723 admissions. Of the former, 80.8% had no limitation of LST, 13.0% had LST withheld, and 6.2% had LST withdrawn. Common independent predictors for withholding and withdrawal were increasing age, absence of chronic kidney dialysis, greater dependence in activities of daily living, cardiopulmonary resuscitation before ICU admission, higher Acute Physiology and Chronic Health Evaluation (APACHE) II score, and higher level of care in the first 24 h of ICU admission. Additional predictors for withholding included being of Chinese race, the religions of Hinduism and Islam, malignancy, and chronic liver failure. The additional predictor for withdrawal was lower hospital paying class (with greater government subsidy for hospital bills). Hospital mortality in patients without LST limitation, with LST withholding, and with LST withdrawal was 10.6%, 82.1%, and 91.8%, respectively (p < 0.001). Withholding (odds ratio 13.822, 95% confidence interval 9.987-19.132) and withdrawal (odds ratio 38.319, 95% confidence interval 24.351-60.298) were both found to be independent predictors of hospital mortality on multivariable analysis.</p><p><strong>Conclusions: </strong>Differences in the independent predictors of withholding and withdrawal of LST exist. Even after accounting for baseline characteristics, both withholding and withdrawal of LST independently predict hospital mortality. Later mortality in patients who had LST withdrawn compared to withholding suggests that the decision to withdraw may be at the point when medical futility is recognised.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":"12 1","pages":"13"},"PeriodicalIF":7.1,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964634/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140288331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for arterial catheter failure and complications during critical care hospitalisation: a secondary analysis of a multisite, randomised trial. 重症监护住院期间动脉导管失败和并发症的风险因素:一项多地点随机试验的二次分析。
IF 7.1 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-03-08 DOI: 10.1186/s40560-024-00719-1
Jessica A Schults, Emily R Young, Nicole Marsh, Emily Larsen, Amanda Corley, Robert S Ware, Marghie Murgo, Evan Alexandrou, Matthew McGrail, John Gowardman, Karina R Charles, Adrian Regli, Hideto Yasuda, Claire M Rickard

Objectives: Arterial catheters (ACs) are critical for haemodynamic monitoring and blood sampling but are prone to complications. We investigated the incidence and risk factors of AC failure.

Methods: Secondary analysis of a multi-centre randomised controlled trial (ACTRN 12610000505000). Analysis included a subset of adult intensive care unit patients with an AC. The primary outcome was all-cause device failure. Secondary outcomes were catheter associated bloodstream infection (CABSI), suspected CABSI, occlusion, thrombosis, accidental removal, pain, and line fracture. Risk factors associated with AC failure were investigated using Cox proportional hazards and competing-risk models.

Results: Of 664 patients, 173 (26%) experienced AC failure (incidence rate [IR] 37/1000 catheter days). Suspected CABSI was the most common failure type (11%; IR 15.3/1000 catheter days), followed by occlusion (8%; IR 11.9/1,000 catheter days), and accidental removal (4%; IR 5.5/1000 catheter days). CABSI occurred in 16 (2%) patients. All-cause failure and occlusion were reduced with ultrasound-assisted insertion (failure: adjusted hazard ratio [HR] 0.43, 95% CI 0.25, 0.76; occlusion: sub-HR 0.11, 95% CI 0.03, 0.43). Increased age was associated with less AC failure (60-74 years HR 0.63, 95% CI 0.44 to 0.89; 75 + years HR 0.36, 95% CI 0.20, 0.64; referent 15-59 years). Females experienced more occlusion (adjusted sub-HR 2.53, 95% CI 1.49, 4.29), while patients with diabetes had less (SHR 0.15, 95% CI 0.04, 0.63). Suspected CABSI was associated with an abnormal insertion site appearance (SHR 2.71, 95% CI 1.48, 4.99).

Conclusions: AC failure is common with ultrasound-guided insertion associated with lower failure rates. Trial registration Australian New Zealand Clinical Trial Registry (ACTRN 12610000505000); date registered: 18 June 2010.

目的:动脉导管(AC)对血流动力学监测和血液采样至关重要,但容易出现并发症。我们调查了 AC 故障的发生率和风险因素:对一项多中心随机对照试验(ACTRN 12610000505000)进行二次分析。分析对象包括使用 AC 的成人重症监护病房患者。主要结果是全因装置故障。次要结果是导管相关血流感染(CABSI)、疑似 CABSI、闭塞、血栓形成、意外移除、疼痛和管路断裂。使用 Cox 比例危险模型和竞争风险模型研究了与 AC 故障相关的风险因素:结果:在 664 名患者中,有 173 人(26%)发生了 AC 失效(发生率 [IR] 37/1000 个导管日)。疑似 CABSI 是最常见的失败类型(11%;IR 15.3/1000,导管天数),其次是闭塞(8%;IR 11.9/1000,导管天数)和意外移除(4%;IR 5.5/1000,导管天数)。有 16 名患者(2%)发生了 CABSI。超声辅助插入可减少全因失败和闭塞(失败:调整后危险比 [HR] 0.43,95% CI 0.25,0.76;闭塞:次危险比 0.11,95% CI 0.03,0.43)。年龄的增加与 AC 故障的减少有关(60-74 岁 HR 0.63,95% CI 0.44 至 0.89;75 岁以上 HR 0.36,95% CI 0.20 至 0.64;参照年龄为 15-59 岁)。女性发生闭塞的比例更高(调整后的次 HR 为 2.53,95% CI 为 1.49 至 4.29),而糖尿病患者发生闭塞的比例较低(SHR 为 0.15,95% CI 为 0.04 至 0.63)。疑似 CABSI 与插入部位外观异常有关(SHR 2.71,95% CI 1.48,4.99):AC 插管失败很常见,但超声引导下的插管失败率较低。试验注册 澳大利亚-新西兰临床试验注册中心(ACTRN 12610000505000);注册日期:2010年6月18日。
{"title":"Risk factors for arterial catheter failure and complications during critical care hospitalisation: a secondary analysis of a multisite, randomised trial.","authors":"Jessica A Schults, Emily R Young, Nicole Marsh, Emily Larsen, Amanda Corley, Robert S Ware, Marghie Murgo, Evan Alexandrou, Matthew McGrail, John Gowardman, Karina R Charles, Adrian Regli, Hideto Yasuda, Claire M Rickard","doi":"10.1186/s40560-024-00719-1","DOIUrl":"10.1186/s40560-024-00719-1","url":null,"abstract":"<p><strong>Objectives: </strong>Arterial catheters (ACs) are critical for haemodynamic monitoring and blood sampling but are prone to complications. We investigated the incidence and risk factors of AC failure.</p><p><strong>Methods: </strong>Secondary analysis of a multi-centre randomised controlled trial (ACTRN 12610000505000). Analysis included a subset of adult intensive care unit patients with an AC. The primary outcome was all-cause device failure. Secondary outcomes were catheter associated bloodstream infection (CABSI), suspected CABSI, occlusion, thrombosis, accidental removal, pain, and line fracture. Risk factors associated with AC failure were investigated using Cox proportional hazards and competing-risk models.</p><p><strong>Results: </strong>Of 664 patients, 173 (26%) experienced AC failure (incidence rate [IR] 37/1000 catheter days). Suspected CABSI was the most common failure type (11%; IR 15.3/1000 catheter days), followed by occlusion (8%; IR 11.9/1,000 catheter days), and accidental removal (4%; IR 5.5/1000 catheter days). CABSI occurred in 16 (2%) patients. All-cause failure and occlusion were reduced with ultrasound-assisted insertion (failure: adjusted hazard ratio [HR] 0.43, 95% CI 0.25, 0.76; occlusion: sub-HR 0.11, 95% CI 0.03, 0.43). Increased age was associated with less AC failure (60-74 years HR 0.63, 95% CI 0.44 to 0.89; 75 + years HR 0.36, 95% CI 0.20, 0.64; referent 15-59 years). Females experienced more occlusion (adjusted sub-HR 2.53, 95% CI 1.49, 4.29), while patients with diabetes had less (SHR 0.15, 95% CI 0.04, 0.63). Suspected CABSI was associated with an abnormal insertion site appearance (SHR 2.71, 95% CI 1.48, 4.99).</p><p><strong>Conclusions: </strong>AC failure is common with ultrasound-guided insertion associated with lower failure rates. Trial registration Australian New Zealand Clinical Trial Registry (ACTRN 12610000505000); date registered: 18 June 2010.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":"12 1","pages":"12"},"PeriodicalIF":7.1,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10924392/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140065257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From bedside to recovery: exercise therapy for prevention of post-intensive care syndrome. 从床边到康复:预防重症监护后综合征的运动疗法。
IF 7.1 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-02-29 DOI: 10.1186/s40560-024-00724-4
Keibun Liu, Oystein Tronstad, Dylan Flaws, Luke Churchill, Alice Y M Jones, Kensuke Nakamura, John F Fraser

Background: As advancements in critical care medicine continue to improve Intensive Care Unit (ICU) survival rates, clinical and research attention is urgently shifting toward improving the quality of survival. Post-Intensive Care Syndrome (PICS) is a complex constellation of physical, cognitive, and mental dysfunctions that severely impact patients' lives after hospital discharge. This review provides a comprehensive and multi-dimensional summary of the current evidence and practice of exercise therapy (ET) during and after an ICU admission to prevent and manage the various domains of PICS. The review aims to elucidate the evidence of the mechanisms and effects of ET in ICU rehabilitation and highlight that suboptimal clinical and functional outcomes of ICU patients is a growing public health concern that needs to be urgently addressed.

Main body: This review commences with a brief overview of the current relationship between PICS and ET, describing the latest research on this topic. It subsequently summarises the use of ET in ICU, hospital wards, and post-hospital discharge, illuminating the problematic transition between these settings. The following chapters focus on the effects of ET on physical, cognitive, and mental function, detailing the multi-faceted biological and pathophysiological mechanisms of dysfunctions and the benefits of ET in all three domains. This is followed by a chapter focusing on co-interventions and how to maximise and enhance the effect of ET, outlining practical strategies for how to optimise the effectiveness of ET. The review next describes several emerging technologies that have been introduced/suggested to augment and support the provision of ET during and after ICU admission. Lastly, the review discusses future research directions.

Conclusion: PICS is a growing global healthcare concern. This review aims to guide clinicians, researchers, policymakers, and healthcare providers in utilising ET as a therapeutic and preventive measure for patients during and after an ICU admission to address this problem. An improved understanding of the effectiveness of ET and the clinical and research gaps that needs to be urgently addressed will greatly assist clinicians in their efforts to rehabilitate ICU survivors, improving patients' quality of survival and helping them return to their normal lives after hospital discharge.

背景:随着重症监护医学的发展,重症监护病房(ICU)的存活率不断提高,临床和研究的注意力也急需转向提高存活质量。重症监护后综合征(PICS)是一种复杂的身体、认知和精神功能障碍,严重影响患者出院后的生活。本综述全面、多角度地总结了目前在重症监护病房入院期间和出院后采用运动疗法(ET)预防和控制重症监护后综合征各方面问题的证据和实践。综述旨在阐明运动疗法在 ICU 康复中的机制和效果的证据,并强调 ICU 患者的临床和功能预后不理想是一个日益严重的公共卫生问题,亟待解决:这篇综述首先简要概述了目前 PICS 与 ET 之间的关系,介绍了有关这一主题的最新研究。随后概述了在重症监护室、病房和出院后使用 ET 的情况,并阐明了这些环境之间的过渡问题。接下来的章节重点讨论了 ET 对身体、认知和精神功能的影响,详细介绍了功能障碍的多方面生物和病理生理机制,以及 ET 在所有三个领域的益处。接下来的一章重点讨论了联合干预以及如何最大限度地提高和增强 ET 的效果,概述了如何优化 ET 效果的实用策略。接下来,综述介绍了几种新兴技术,这些技术已被引入/建议用于增强和支持在重症监护室入院期间和之后提供的急救技术。最后,综述讨论了未来的研究方向:PICS 是全球日益关注的医疗问题。本综述旨在指导临床医生、研究人员、政策制定者和医疗服务提供者在患者入住 ICU 期间和之后利用 ET 作为治疗和预防措施,以解决这一问题。更好地了解 ET 的有效性以及急需解决的临床和研究缺口,将极大地帮助临床医生努力帮助 ICU 存活者康复,改善患者的生存质量,并帮助他们在出院后恢复正常生活。
{"title":"From bedside to recovery: exercise therapy for prevention of post-intensive care syndrome.","authors":"Keibun Liu, Oystein Tronstad, Dylan Flaws, Luke Churchill, Alice Y M Jones, Kensuke Nakamura, John F Fraser","doi":"10.1186/s40560-024-00724-4","DOIUrl":"10.1186/s40560-024-00724-4","url":null,"abstract":"<p><strong>Background: </strong>As advancements in critical care medicine continue to improve Intensive Care Unit (ICU) survival rates, clinical and research attention is urgently shifting toward improving the quality of survival. Post-Intensive Care Syndrome (PICS) is a complex constellation of physical, cognitive, and mental dysfunctions that severely impact patients' lives after hospital discharge. This review provides a comprehensive and multi-dimensional summary of the current evidence and practice of exercise therapy (ET) during and after an ICU admission to prevent and manage the various domains of PICS. The review aims to elucidate the evidence of the mechanisms and effects of ET in ICU rehabilitation and highlight that suboptimal clinical and functional outcomes of ICU patients is a growing public health concern that needs to be urgently addressed.</p><p><strong>Main body: </strong>This review commences with a brief overview of the current relationship between PICS and ET, describing the latest research on this topic. It subsequently summarises the use of ET in ICU, hospital wards, and post-hospital discharge, illuminating the problematic transition between these settings. The following chapters focus on the effects of ET on physical, cognitive, and mental function, detailing the multi-faceted biological and pathophysiological mechanisms of dysfunctions and the benefits of ET in all three domains. This is followed by a chapter focusing on co-interventions and how to maximise and enhance the effect of ET, outlining practical strategies for how to optimise the effectiveness of ET. The review next describes several emerging technologies that have been introduced/suggested to augment and support the provision of ET during and after ICU admission. Lastly, the review discusses future research directions.</p><p><strong>Conclusion: </strong>PICS is a growing global healthcare concern. This review aims to guide clinicians, researchers, policymakers, and healthcare providers in utilising ET as a therapeutic and preventive measure for patients during and after an ICU admission to address this problem. An improved understanding of the effectiveness of ET and the clinical and research gaps that needs to be urgently addressed will greatly assist clinicians in their efforts to rehabilitate ICU survivors, improving patients' quality of survival and helping them return to their normal lives after hospital discharge.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":"12 1","pages":"11"},"PeriodicalIF":7.1,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10902959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139996437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Intensive Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1